The eVTOL sector traded like a risk asset again today, but the weakness was telling three different stories. Joby closed at $8.105, down 4.31%, Archer closed at $5.10, down 5.03%, and EHang finished at $9.39, down 3.20%. All three are under pressure, yet the market is not punishing them for the same reason.
For today’s detailed market data, see Joby Daily, Archer Daily, and EHang Daily.
Here’s the thing: this market is becoming much less patient with broad future stories. Investors want to know whether a company can turn policy access into actual aircraft deployment, whether liquidity can bridge a long revenue vacuum, and whether a company with limited fresh news can still hold attention when rivals keep producing measurable milestones. That is why Joby’s 10-state footprint, Archer’s cash cushion, and EHang’s valuation all need to be read more critically now.
Q1: JOBY는 eIPP 조기운항 대상 주가 10개인데 2027년 생산 목표는 월 4대(연 48대), 장기 잠재능력은 연 500대다. 같은 날 ACHR은 미국 3개 주만 파일럿 프로그램에 올랐다. 초기 운항 지역 수는 JOBY가 3.3배 넓지만 초기 생산 숫자는 아직 제한적일 때, 10개 주 확장은 우위 신호인가 아니면 기체 배분 리스크를 키우는 과속 신호인가?
It is more of an advantage signal than a red flag, but only if Joby stays disciplined about where those aircraft actually go.
The headline difference is obvious. Joby says it has access to early operations across 10 states under the White House-backed eIPP structure, while Archer highlighted pilot program presence in just three states: Florida, New York, and Texas. On paper, that gives Joby a much wider geographic footprint. If investors only care about political reach and regulatory positioning, Joby clearly looks ahead.
But the market is not stupid. It can also do the supply math. Joby’s own March 13 summary says the company is targeting production of up to four aircraft per month in 2027, or 48 aircraft annually. Yes, management also points to long-term potential capacity of 500 aircraft per year, backed by a 700,000 square foot Ohio facility. The problem is that long-term capacity does not solve the near-term fleet constraint. What matters for 2026 and 2027 is not theoretical scale. It is how many deployable aircraft exist during the first commercial window.
That is where the nuance matters. A 10-state operating opportunity does not mean Joby plans to launch broad service in all 10 states at once. It means the company has far more optionality than Archer. Optionality is valuable because early winners in this industry will likely be the companies that can choose the best launch nodes rather than the companies forced into a narrow set of locations. Joby can prioritize corridors with supportive regulators, better infrastructure, stronger strategic partners, or cleaner demonstration value. Archer, with three states listed, simply has less room to optimize.
Still, investors should not treat that 10-state figure as if it automatically translates into faster revenue. Early aircraft are going to be scarce, and they are not all available for commercial use. Joby’s March 11 update says its first FAA-conforming aircraft has started flight testing and is intended to support future “for credit” TIA work. That means some of the limited fleet remains tied to certification tasks. Other aircraft will be needed for pilot training, maintenance planning, demonstrations, and readiness work. So even if 48 aircraft per year sounds decent, the usable commercial fleet in the earliest phase could be materially smaller.
That is why I would not call this over-acceleration yet. I would call it a strategic edge with a built-in execution trap. If Joby tries to satisfy every opportunity at once, the 10-state footprint becomes a distraction. Sparse fleets do not create strong networks. Concentrated fleets do. Early operations in advanced air mobility need reliability, high utilization, and visible success more than map coverage.
The market reaction hints that investors understand that tension. JOBY still fell 4.31% to $8.105, with volume at 27,467,674. The technical picture remains weak too, with SMA5 at $8.76, SMA20 at $9.53, and RSI14 at 22.3. So investors are not rewarding the policy headline on its own. They want evidence that the company can convert that broad access into a focused launch plan.
Let’s break this down. If Joby uses those 10 states to pick just a handful of high-probability launch environments, the breadth is a real competitive advantage over Archer’s three-state setup. If it behaves as though every state is an immediate operating commitment, then the same breadth becomes an allocation burden. My read today is that the 10-state expansion is still a bullish signal, but only because it creates choice. The risk is not the footprint itself. The risk is what management does with it.
Q2: ACHR는 Q4 매출이 $0.30M인데 분기 손실은 EPS -$0.26, 시가총액은 $3.79B, current ratio는 19.89다. 여기에 최근 90일 insider 매도 380,750주와 Eric Lentell의 3월 매도 95,449주가 겹쳤다. 현금은 버티는데 매출은 거의 없는 상태라면, 시장이 ACHR를 ‘유동성 부족’이 아니라 ‘상용화 전 매출 공백이 너무 긴 회사’로 할인하기 시작한 것 아닌가?
Yes. That is exactly what the discount looks like now.
Archer’s liquidity picture is not the main problem in today’s file set. A current ratio of 19.89 tells you the company is not being priced like an imminent short-term cash crisis. If the market believed bankruptcy or near-term liquidity stress was the core issue, you would expect a different kind of discussion around solvency urgency. Instead, the more uncomfortable contrast is between valuation and commercial reality.
Start with the mismatch. Archer’s Q4 revenue was just $0.30 million, while the company still carries a market capitalization of $3.79 billion. EPS for the quarter was negative $0.26. That is not unusual for a pre-commercial eVTOL company by itself, but it becomes harder to defend when the timeline to scaled revenue still looks extended. Investors can tolerate losses when they believe revenue is about to inflect. They become much harsher when the bridge to meaningful revenue keeps stretching.
That is why the insider data matters so much. The question file cites 380,750 shares sold by insiders over the last 90 days. It also highlights Eric Lentell’s March sales totaling 95,449 shares, with combined proceeds of $560,146.21. None of that automatically proves management lacks conviction. Some insider sales are routine. But market psychology matters. When a company has almost no current revenue and insiders are selling into the story, investors start to ask whether the wait to commercialization is getting longer than the stock can comfortably support.
The tape supports that interpretation. ACHR closed at $5.10, down 5.03%, with volume at 28,396,482. Technically the stock looks stressed: SMA5 is $5.49, SMA20 is $6.14, and RSI14 is 21.83. That is deep oversold territory. Oversold does not mean misunderstood. Sometimes it means the market is repricing something painful before fundamentals visibly catch up.
What keeps this from being a pure liquidity story is that Archer still has real strategic progress to point to. The company says U.S. and UAE pilot programs remain on track for 2026, and it has White House pilot program selection in Florida, New York, and Texas. Those are meaningful milestones. If investors were mainly worried about access to capital, those program announcements would probably carry more relief value. Instead, the stock is still being marked down because the market is focused on the absence of commercial proof.
In other words, the market seems to be saying this: fine, Archer may survive financially for now, but how long does the business remain in this low-revenue zone before investors demand a much lower valuation? That is a harsher question than “does Archer have enough cash?” It is a question about time-to-revenue credibility.
For investors, this is the crucial distinction. A liquidity discount can reverse sharply on financing clarity. A long-revenue-gap discount is harder to fix because it requires either real commercial conversion or a much more convincing proof that revenue acceleration is close. Right now Archer does not look like a company being punished for running out of cash tomorrow. It looks like a company being punished because the market is tired of capitalizing a future revenue story that still barely shows up in the income statement.
Q3: EH는 종가 $9.39로 하루 -3.20% 하락했지만, 같은 섹터 기사에서 Eve는 2025년 12월 이후 35회 비행·총 1.5시간·최대 140ft까지 실증을 공개했고, 일본은 상용 eVTOL 운항 개시 목표를 2027~2028년으로 제시했다. EHang 관련 공식 원문은 0건인데 경쟁사와 정책 타임라인은 숫자로 계속 쌓이고 있다면, EH 할인은 회사 자체 뉴스 부족 때문인지 아니면 시장이 ‘비중국권 일정이 더 구체적’이라고 보기 시작한 결과인지?
It looks like both, but the bigger issue is that non-China timelines are becoming easier for the market to underwrite.
EHang did not suffer from a company-specific disaster in today’s files. In fact, the most striking detail is the absence of fresh official EHang-originated material. The EHang article summary explicitly notes that there was no IR section for the day. When a stock is already weak, silence is not neutral. Silence creates space for the market to compare you against whoever is generating the clearest measurable progress.
That comparison did not help EHang today. Eve disclosed 35 flights since December 2025, around 1.5 total flight hours, and a peak test altitude of 140 feet, or 43 meters. Japan’s updated AAM roadmap also put concrete commercial eVTOL operations in the 2027 to 2028 window, with remotely controlled passenger transport in the early 2030s and partial autonomous operations in the late 2030s. Those numbers matter because they make the future feel schedulable. Investors may still discount them, but they can at least map them.
EHang, by contrast, offered no fresh official numbers in this set. That leaves the stock trading mainly on sector sentiment and relative narrative weakness. EH closed at $9.39, down 3.20%, with volume of 470,357. The technical structure is soft as well: SMA5 sits at $9.88, SMA20 at $11.13, and RSI14 at 26.0. That is not a collapse, but it is the profile of a stock under sustained pressure.
The key shift is this: the market may be starting to prefer specificity over broad strategic possibility. Non-China players and policy frameworks are producing milestones that can be counted, timed, and compared. Eve gives flight counts and hours. Japan gives target operating windows. Vertical talks about supplier decisions tied to certification protection. Even if none of those stories guarantees success, they create a more legible path for investors.
EHang is suffering because it lacks that same fresh, comparable cadence in today’s materials. So yes, the company’s own news scarcity is part of the discount. But the deeper problem is relative. When competitors and policymakers keep putting numbers on the board, the market starts to treat the side with fewer visible milestones as the less concrete story.
I would not frame this as a simple anti-China trade from the evidence we have today. The file set does not prove that. What it does show is that investors currently have more timestamped progress markers outside EHang’s own news flow than inside it. That makes the non-China narrative easier to model, and in markets, easier to model often means easier to own.
What to Watch Tomorrow
First, watch whether Joby starts showing signs that it can translate 10-state optionality into a concentrated launch strategy rather than a scattered ambition story.
Second, watch whether Archer puts out anything that shortens the perceived revenue gap, because that looks like the market’s real valuation problem now.
Third, watch whether EHang produces fresh company-specific numbers, not just sector-adjacent context, because the stock currently looks vulnerable to being defined by other people’s milestones.
This is not financial advice. Do your own research.
Follow @futurewatchlog for daily eVTOL coverage.
Previous insight: eVTOL Daily Insight – 2026-03-27